Human Exendin-4 ELISA Kit

Name: Human Exendin-4 ELISA Kit
SKU: DEIABL227
Rating: 5 (1 reviews)

Regulatory status: For research use only, not for use in diagnostic procedures.

COA

SDS

Datasheet

Summary

Sample

Human serum or plasma

Detection Method

cELISA

Intended Use

For the quantitative determination of Exendin-4 in human serum or plasma using competitive ELISA method.

Contents of Kit

1.ELISA buffer concentrate (50ml 20x concentrate)
2.96-well immunoplate with plate sealer
3.Antiserum (lyophilized powder)
4.Standard (1mg lyophilized powder)
5.Biotinylated tracer (lyophilized powder)
6.Streptavidin-HRP (100μl 200x concentrate)
7.TMB substrate stock solution (1.5ml)
8.TMB substrate buffer (15ml citrate buffer)
9.Stop solution 2 N HCl (15 ml)
10.Standard diluent 8 ml (peptide-free human serum)
11.Datasheet
12.Protocols

Storage

After you receive the kit, store the lyophilized components and standard diluent at -20°C for up to one year from the kit's assembly date. The remaining components should be stored in the refrigerator (4 - 8°C) also up to 1 year. Long term storage, improper storage conditions and large temperature fluctuation cycles may cause precipitates in the TMB solution and in the ELISA buffer concentrate. These precipitates should not affect the assay noticeably. Nevertheless, if you observe such precipitates, we recommend to avoid them by allowing them to sink to the bottom.

Detection Range

0-25ng/ml

General Description

Exendin-4 is a 39 amino acid peptide amide known to be a long-acting agonist of the glucagon-like peptide 1 receptor (GLP-1). It is involved in glucose-dependent enhancement of insulin secretion, reduction of hyperglycemia, and glucosedependent suppression of high glucagon secretion.
This ELISA was developed with serum from rabbits immunized with Exendin-4 coupled to a carrier protein.

Standard Curve

Citations

Have you cited DEIABL227 in a publication? Let us know and earn a reward for your research.

Documents

pdf COA

pdf SDS

pdf Datasheet

QA & Reviews

Q & A

Ask a Question

Q: Is this kit suitable for plasma, urine, CSF and cell lysate samples?

A: We only tested this kit for plasma, but not for other samples.

Customer Reviews

References

Repurpose of exendin-4 for the treatment of preterm neonatal brain injury

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Authors: Ferreira, E. Rocha; Jonsdotter, A.; Jinnai, M.; Poupon, L.; Leverin, A. L.; Carlsson, Y.; Rahim, A. A.; Hagberg, H.

Abstract

Inhibitory effects of peripheral administration of exendin-4 on food intake are attenuated by lesions of the central nucleus of amygdala

BRAIN RESEARCH BULLETIN

Authors: Qiao, Hu; Ren, Wan-ni; Li, Hai-zhen; Hou, Yu-xia

Abstract

The long-acting glucagon-like peptide-1 receptor (GLP-1R) agonist exendin-4 suppresses food intake and decreases body weight. However, the mediating site(s) of action of the anorectic effects induced by peripheral administration of GLP-1R agonists are not well known. The present study investigated the effects of bilateral lesions of the central nucleus of the amygdala (CeA) on the suppression of chow and high-sucrose food intake by exendin-4 in rats. Adult male Sprague-Dawley rats with bilateral sham or electrolytic lesions (400 mu A; 25 s) of the CeA were used for this experiment. No significant difference was found in the daily chow intake and high-sucrose food intake in rats with CeA lesion compared to sham-operated rats. Bilateral lesions of the CeA significantly attenuated the suppression of high-sucrose food intake by i.p. exendin-4, but not the suppression of chow intake. These results suggest that a mediating role of the CeA on the peripheral effects of exendin-4.